Induction of apoptosis by linoleic acid is associated with the modulation of Bcl-2 family and Fas/FasL system and activation of caspases in AGS human gastric adenocarcinoma cells

Journal of Medicinal Food

Volumn 11, Issue 1, 2008, Pages 1-8

  Kwon, Jae Im ^a   Kim, Gi Young ^b   Park, Kun Young ^c   Ryu, Chung Ho ^d   Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

^b Jeju National University   (South Korea)

^c Pusan National University   (South Korea)

^d Gyeongsang National University   (South Korea)

Author keywords

Apoptosis; Bax Bcl 2; Caspase; Fas Fas ligand; Gastric cancer cells; Linoleic acid

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FAS ANTIGEN; FAS LIGAND; LINOLEIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOLIPASE C GAMMA1; POLYUNSATURATED FATTY ACID; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; VEGETABLE OIL;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME DEGRADATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANTIGENS, CD95; APOPTOSIS; CASPASES; CELL DIVISION; CELL LINE, TUMOR; ENZYME ACTIVATION; FAS LIGAND PROTEIN; GENE EXPRESSION; HUMANS; LINOLEIC ACID; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; STOMACH NEOPLASMS; TYPE C PHOSPHOLIPASES;

EID: 41349110485     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.073     Document Type: Article

References (36)

1. Colquhoun A, Curi R: Effects of saturated and polyunsaturated fatty acids on human tumor-cell proliferation. Gen Pharmacol 1998;30:191-194.
2. Schaffer JE: Fatty acid transport: the roads taken. Am J Physiol Endocrinol Metab 2002;282:E239-E246.
3. Madhavi N, Das UN: Effect of n-6 and n-3 fatty acids on the survival of vincristine sensitive and resistant human cervical carcinoma cells in vitro. Cancer Lett 1994;84:31-41.
4. Karmali RA, Adams L, Trout JR: Plant and marine n-3 fatty acids inhibit experimental metastasis of rat mammary adenocarcinoma cells. Prostaglandins Leukot Essent Fatty Acids 1993;48:309-314.
5. Alison C, Rui C: Effects of saturated and polyunsaturated fatty acids on human tumor-cell proliferation. Gen Pharmacol 1998;30:191-194.
6. Andrade LN, Lima TM, Curi R, Castrucci AM: Toxicity of fatty acids on murine and human melanoma cell lines. Toxicol In Vitro 2005;19:553-560.
7. Awad AB, Kamei A, Horvath PJ, Fink CS: Prostaglandin synthesis in human cancer cells: influence of fatty acids and butyrate. Prostaglandins Leukot Essent Fatty Acids 1995;53:87-93.
8. Chen ZY, Istfan NW: Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins Leukot Essent Fatty Acids 2000;63:301-308.
9. Tsai WS, Nagawa H, Kaizaki S, Tsuruo T, Muto T: Inhibitory defects of n-3 polyunsaturated fatty acids on sigmoid colon cancer transformants. J Gastroenterol 1998;33:206-212.
10. Reddy BS, Burill C, Rigotty J: Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 1991;51:487-491.
11. Reddy BS, Simi B, Patel N, Aliaga C, Rao CV: Effect of amount and types of dietary fat intestinal bacterial 7α-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during different stages of colon tumor promotion. Cancer Res 1996;56:2314-2320.
12. Howe GR, Aronson KJ, Benito E, Castelleto R, Cornée J, Duffy S, Gallagher RP, Iscovich JM, Deng-ao J, Kaaks R, Kune GA, Kune S, Lee HP, Lee M, Miller AB, Peters RK, Potter JD, Riboli E, Slattery ML, Trichopoulos D, Tuyns A, Tzonou A, Watson LF, Whittemore AS, Wu-Williams AH, Shu Z: The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 1997;8:215-228.
13. Zock PL, Katan MB: Linoleic acid intake and cancer risk: a review and meta-analysis. Am J Clin Nutr 1998;68:142-153.
14. Begin ME, Dae UN, Ells G, Horrobin DF: Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukot Med 1985;19:177-186.
15. Park KY, Jung KO, Rhee SH, Choi YH: Antimutagenic effects of doenjang (Korean fermented soypaste) and its active compounds. Mutat Res 2003;324:43-53.
16. Park KY, Lee JM, Moon SH, Jung KO: Inhibitory effect of Doenjang (fermented Korean soy paste) extracts and linoleic acid on the growth of human cancer cell lines. J Food Sci Nutr 2000;5:114-118.
17. Norman A, Bennett L, Mead JF, Iwamoto KS: Antitumor activity of sodium linoleate. Nutr Cancer 1988;11:107-115.
18. Nimmanapalli R, Bhalla K: Targets in apoptosis signaling: promise of selective anticancer therapy. Methods Mol Biol 2003;223:465-483.
19. Hetz CA, Torres V, Quest AF: Beyond apoptosis: nonapoptotic cell death in physiology and disease. Biochem Cell Biol 2005;83:579-588.
20. Jin Z, el-Deiry WS: Overview of cell death signaling pathways. Cancer Biol Ther 2005;4:139-163.
21. Kavurma MM, Khachigian LM: Signaling and transcriptional control of Fas ligand gene expression. Cell Death Differ 2003;10:36-44.
22. Breckenridge DG, Xue D: Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr Opin Cell Biol 2004;16:647-652.
23. de Graaf AO, de Witte T, Jansen JH: Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer? Leukemia 2004;18:1751-1759.
24. Phoon MC, Desbordes C, Howe J, Chow VT: Linoleic and linolelaidic acids differentially influence proliferation and apoptosis of MOLT-4 leukemia cells. Cell Biol Int 2001;25:777-784.
25. Chamras H, Ardashian A, Heber D, Glaspy JA: Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J Nutr Biochem 2002;13:711-716.
26. Bae SS, Perry DK, Oh YS, Choi JH, Galadari SH, Ghayur T, Ryu SH, Hannun YA, Suh PG: Proteolytic cleavage of phospholipase C-γ1 during apoptosis in Molt-4 cells. FASEB J 2000;14:1083-1092.
27. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994;371:346-347.
28. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825.
29. Esposito F, Russo L, Chirico G, Ammendola R, Russo T, Cimino F: Regulation of p21waf1/cip1 expression by intracellular redox conditions. IUBMB Life 2001;52:67-70.
30. Yu J, Zhang L: The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 2005;331:851-858.
31. Gartel AL, Tyner AL: The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002;1:639-649.
32. Jerry DJ, Dickinson ES, Roberts AL, Said TK: Regulation of apoptosis during mammary involution by the p53 tumor suppressor gene. J Dairy Sci 2002;85:1103-1110.
33. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998;281:1312-1316.
34. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC: Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 1999;18:5242-5251.
35. Bennet M, MacDonald K, Cha SW, Luzio JP, Simari R, Weissberg P: Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 1998;282:290-293.
36. Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fonta A, Tschopp J: Conversion of membrane-bound Fas (CD95) ligand to is soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998;187:1205-1213.